New data on Mpox vaccine effectiveness Date: March 19, 2025 Source: Charité - Universitätsmedizin Berlin Summary: A study has found that a single dose of the Imvanex vaccine provides protection ...

Clade I, the culprit in the current 2025 version of global epidemic mpox, is highly transmissible and is spreading within families and among children, whereas the 2022 Clade II mpox - still ...

"Taken together, these latest results also highlight that we still have yet to isolate which factors influence mpox disease progression and clinical resolution." More information: Wilkin et al.

KARACHI: Following the detection of the first mpox case in Karachi, the provincial health department has requested the concerned authorities to accelerate the screening of all passengers entering ...

A study at Charité – Universitätsmedizin Berlin has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% effectiveness. For people with HIV, however, a single dose ...

As mpox continues to spread within the Democratic Republic of Congo and neighbouring countries, concern is growing over how best to respond to this second mpox Public Health Emergency of International ...

Tecovirimat failed to reduce clade II mpox lesions, pain or viral clearance among participants in a study of the antiviral ...

Pakistan confirmed the second case of mpox this year when a 29-year-old man tested positive for the contagious viral infection in Karachi, according to a media report. The patient, a resident of Shah ...

Pakistan has reported its second case of mpox this year, with a 29-year-old man from Karachi testing positive for the viral infection. This marks the first case in Sindh and follows an earlier ...

PESHAWAR: The Khyber Pakhtunkhwa health department has detected a new mpox case in the provincial capital, taking the total number of patients infected with zoonotic ailment in the province this ...

"Taken together, these latest results also highlight that we still have yet to isolate which factors influence mpox disease progression and clinical resolution." The STOMP study was conducted by the ...